Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Recombinant human bone morphogenetic

Yim, K., Abrams, J., and Hsu, A. (1995). Gapillary zone electrophoretic resolution of recombinant human bone morphogenetic protein-2 glycoforms — an investigation into the separation mechanisms for an exquisite separation. /. Chromatogr. A 716, 401—412. [Pg.303]

Paralkar, V,M, Weeks, B,S, Yu, Y,M Kleinmann, H,K, and Reddi, A,H, (1992) Recombinant human bone morphogenetic protein 2B stimulates PC 12 cell differentiation potentiation and binding to type IV collagen, J. Cell Biol. 119 1721-1728,... [Pg.395]

Cui X et al (2008) Effects of chitosan-coated pressed calcium sulfate pellet combined with recombinant human bone morphogenetic protein 2 on restoration of segmental bone defect. J Craniofac Surg 19(2) 459 65... [Pg.164]

Alt, V., Fleissel, A. 2006. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe the German model. Curr Med Res Opin 22 Suppl 1, SI9-22. [Pg.219]

Dimar, J.R., Glassman, S.D., Burkus, K.J., Carreon, L.Y. 2006. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31(22), 2534-2539, discussion, 2540. [Pg.221]

Mummaneni, P.V., Pan, J., Haid, R.W., Rodts, G.E. 2004. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 1(1), 19-23. [Pg.224]

Vaidya, R., Carp, J., Sethi, A., Bartol, S., Craig, J., Les, C.M. 2007. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16(8), 1257-1265. [Pg.226]

Winn SR, Ulundag H, Hollinger JO. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliver Rev 1998 31 303-18. [Pg.76]

Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery emerging safety concerns and lessons learned. Spine J 2011 11 471-91. [Pg.76]

Figure 4.4 Design and fabrication of the osteophilic multilayer architecture. Components of the film (a) Chitosan (75-85% deacetylated chitin) a polycation (b) Poly(acrylic acid) (PAA) (c) A hydrolytically degradable poly(p-amino ester) (Poly2), a polycation and (d) osteoinductive recombinant human bone morphogenetic protein 2 (rhBMP-2) (e) Schematic of the modular electrostatic assembly. Osteoconductive hydroxyapatite (HAP) is complexed with chitosan and incorporated into nanoscale thick films along with poly(acrylic acid) in a bilayer architecture. A hydrolytically degradable poly(P-amino ester)-based multilayer fihn incorporating osteoinductive rhBMP-2 lays atop the osteoconductive layer, (f)... Figure 4.4 Design and fabrication of the osteophilic multilayer architecture. Components of the film (a) Chitosan (75-85% deacetylated chitin) a polycation (b) Poly(acrylic acid) (PAA) (c) A hydrolytically degradable poly(p-amino ester) (Poly2), a polycation and (d) osteoinductive recombinant human bone morphogenetic protein 2 (rhBMP-2) (e) Schematic of the modular electrostatic assembly. Osteoconductive hydroxyapatite (HAP) is complexed with chitosan and incorporated into nanoscale thick films along with poly(acrylic acid) in a bilayer architecture. A hydrolytically degradable poly(P-amino ester)-based multilayer fihn incorporating osteoinductive rhBMP-2 lays atop the osteoconductive layer, (f)...
Rodeo SA, Suzuki K, Deng XH, Wozney J and Warren EF. Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. Am J Sports Med. 1999 27 476-488. [Pg.634]

Polyurethane scaffolds Recombinant human bone morphogenetic protein (rhBMP)... [Pg.223]

Local delivery of recombinant human bone morphogenetic protein-2... [Pg.492]

Swiontkowski ME, et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 2006 88(6) 1258-65. [Pg.497]

Glassman SD, et al. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/ collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) 2005 30( 15) 1694—8. [Pg.497]

McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007 31(6) 729-34. [Pg.497]

Kim J, Hollinger JO. Recombinant human bone morphogenetic protein-2 released from polyurethane-based scaffolds promotes early osteogenic differentiation of human mesenchymal stem cells. Biomed Mater 2012 7(4) 045008. [Pg.500]

See other pages where Recombinant human bone morphogenetic is mentioned: [Pg.101]    [Pg.269]    [Pg.221]    [Pg.399]    [Pg.428]    [Pg.195]    [Pg.9]    [Pg.22]    [Pg.55]    [Pg.83]    [Pg.448]    [Pg.488]    [Pg.482]    [Pg.167]    [Pg.76]    [Pg.78]    [Pg.82]    [Pg.148]    [Pg.95]    [Pg.344]    [Pg.55]    [Pg.236]    [Pg.240]    [Pg.483]   


SEARCH



BONE MORPHOGENETIC

Human bone

Recombinant human

Recombinant human bone morphogenetic protein-2 (rhBMP

Recombinant human bone morphogenetic proteins

Recombinant human bone morphogenetic rhBMP

© 2024 chempedia.info